Trial Profile
Randomized Clinical Comparison of the Xience V and the Cypher Coronary Stents in Non-Selected Patients With Coronary Heart Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms SORT-OUT-IV
- 02 Nov 2017 Results assessing 5-year risk of target lesion revascularization in patients with and without ACS from 3 randomised trials (SORT OUT III, SORT OUT IV and SORT OUT V; n=6524) presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
- 30 Aug 2017 Results of a pooled analysis of the SORT OUT III, IV, and V studies presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
- 30 Aug 2017 Resultsof a pooled analysis of the SORT OUT III, IV, and V trials, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology